A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates

Human Reproduction

Volumn 21, Issue 10, 2006, Pages 2645-2649

  Lahoud, R ^a   Al Jefout, M ^b   Tyler, J ^a   Ryan, J ^a   Driscoll, G ^a  

^a IVFAustralia   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

GnRH agonist; IVF; LH; Live birth rate; Pituitary suppression

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; NAFARELIN; NAFARELIN ACETATE; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; EMBRYO; EMBRYO DISPOSITION; EMBRYO MORTALITY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONE RESPONSE; HUMAN; HYPOPHYSIS FUNCTION; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; OOCYTE TRANSPORT; OUTCOMES RESEARCH; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

EID: 33749595641     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del219     Document Type: Article

References (22)

1. Balasch J, Miro F, Burzaco I, Casamitjana R, Civico S, Ballesca JL, Puerto B and Vanrell JA (1995) The role of luteinizing hormone in human follicle development and oocyte fertility: Evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human FSH. Hum Reprod 10,1678-1683.
2. Balasch J, Vidal E, Penarrubia J, Casamitjana R, Carmona F, Creus M, Fabregues F and Vanrell JA (2001) Suppression of LH during ovarian stimulation: Analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 16,1636-1643.
3. Cabrera RA, Stadtmauer L, Mayer JF, Gibbons WE and Oehninger S (2005) Follicular phase serum levels of lutenizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone. Fertil Steril 83(1),42-48.
4. Daya S and Gunby J (2000) Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles. The Cochrane Database of Systematic Reviews 2000, Issue 3. Art. no. CD002810. DOI: 10.1002/14651858.CD002810.
5. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N and Mollo A (on behalf of the Italian Collaborative Group on Recombinant Human Luteinizing Hormone) (2005) Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 20(2),390-396.
6. Esposito MA, Barnhart KT, Coutifaris C and Patrizio P (2001) Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 75,519-524.
7. The European Recombinant Human LH Study Group (1998) Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH deficient anovulatory women: A dose-finding study. J Clin Endocrinol Metab 83,1507-1514.
8. Falck B (1959) Site of production of oestrogen in rat ovary as studied by microtransplants. Acta Physiol Scand 47,1-101.
9. Fleming R, Chung CC, Yates RW and Coutts JR (1996) Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum Reprod 11,1854-1858.
10. Fleming R, Lloyd F, Herbert M, Fenwick J, Griffiths T and Murdoch A (1998) Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 13,1788-1792.
11. Fleming R, Rehka P, Deshpande N, Jamieson ME, Yates RWS and Lyall H (2000) Suppression of LH during ovarian stimulation: Effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum Reprod 15(7),1440-1445.
12. Humaidan P, Bungum L, Bungum M and Andersen CY (2002) Ovarian response and pregnancy outcome related to mid-follicular LH concentrations in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 17(8),2016-2021.
13. Humaidan P, Bungum M, Bungum L and Andersen CY (2004) Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH. RBM Online 8(6),635-643.
14. Kol S (2005) To add or not to add LH: Consideration of LH concentration changes in individual patients. RBM Online 11(6),664-666.
15. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E and Devroey P (2006) Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic to view. Hum Reprod Update 12(1),3-12.
16. Lisi F, Rinaldi L, Fishel S, Caserta D, Lisi R and Campbell A (2005) Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril 83(2),309-315.
17. Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L and Kelly E (2004) Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. RBM Online 8(2),175-182.
18. Penarrubia J, Fabregues F, Creus M, Manau D, Casamitjana R, Guimera M, Carmona F, Vanrell JA and Balasch J (2003) LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod 18(12),2689-2697.
19. Porter RN, Smith W, Craft IL, Abdulwahid NA and Jacobs HS (1984) Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 2,1284-1285.
20. Tarlatzis B, Tavmergen E, Szamatowicz M, Barash A, Amit A, Levitas E and Shoham Z (2006) The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: A double-blind, randomised, prospective study. Hum Reprod 21(1),90-94.
21. Westergaard LG, Laursen SB and Yding Andersen C (2000) Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in IVF treated normogonadotrophic women. Hum Reprod 15,1003-1008.
22. Zeleznik AJ and Hillier SG (1984) The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 27,927-940.